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Abstract
In obstructive cholestasis, there is an integral adaptive response aimed to diminish the bile
flow and minimize the injury of bile ducts caused by increased intraluminal pressure and
harmful levels of bile salts and bilirrubin. Canalicular bicarbonate secretion, driven by the
anion exchanger 2 (AE2), is an influential determinant of the canalicular bile salt-indepen-
dent bile flow. In this work, we ascertained whether AE2 expression and/or activity is
reduced in hepatocytes from rats with common bile duct ligation (BDL), as part of the adap-
tive response to cholestasis. After 4 days of BDL, we found that neither AE2 mRNA expres-
sion (measured by quantitative real-time PCR) nor total levels of AE2 protein (assessed by
western blot) were modified in freshly isolated hepatocytes. However, BDL led to a decrease
in the expression of AE2 protein in plasma membrane fraction as compared with SHAM con-
trol. Additionally, AE2 activity (JOH-, mmol/L/min), measured in primary cultured hepatocytes
from BDL and SHAM rats, was decreased in the BDL group versus the control group (1.9 ±
0.3 vs. 3.1 ± 0.2, p<0.005). cAMP-stimulated AE2 activity, however, was not different
between SHAM and BDL groups (3.7 ± 0.3 vs. 3.5 ± 0.3), suggesting that cAMP stimulated
insertion into the canalicular membrane of AE2-containing intracellular vesicles, that had
remained abnormally internalized after BDL. In conclusion, our results point to the existence
of a novel adaptive mechanism in cholestasis aimed to reduce biliary pressure, in which
AE2 internalization in hepatocytes might result in decreased canalicular HCO3- output and
decreased bile flow.
Introduction
Bile formation involves an osmotic water flow in response to active solute transport. Bile salts
are secreted to the canaliculi through a specific export pump referred to as BSEP (ABCB11)
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[1], allowing for the generation of the bile salt-dependent fraction of bile flow. The remaining
bile salt-independent fraction of bile flow is driven by supplementary solutes secreted at both
the canalicular and the ductular levels (the so-called canalicular bile salt-independent bile flow,
and ductular bile salt-independent bile flow, respectively) [2].
In addition to bile salt secretion, the hepatocellular canalicular membranes shows active
secretion of other organic and inorganic compounds, mainly glutathione [3] and HCO3
- [4],
respectively. Glutathione can be secreted via the organic anion transporter MRP2 (ABCC2)
[5], while the efflux of HCO3
- occurs through a Na+-independent Cl-/HCO3
- exchanger (AE2,
SLC4A2) [4]. AE2 functions in connection with an apical chloride channel that maintains
favorable Cl- gradients and with the canalicular water channel aquaporin 8 (AQP8) [4]. AE2
requires suitable intracellular levels of HCO3
-, which are achieved through both its cotransport
with Na+ by the electrogenic sodium/bicarbonate (NBCe) symporter in the sinusoidal mem-
brane and its formation, catalized by the intracellular carbonic anhydrase. This latter process is
linked to H+ extrusion via the Na+/H+ exchanger (NHE), in both the basolateral (NHE1) and
the canalicular (NHE3) membranes, Na+ being extruded via the basolateral pump, Na+/K+-
ATPase [4]. ATP dependence of this latter process makes HCO3
- secretion a concentrative
mechanism, thus allowing the generation of osmotic canalicular gradients that drive canalicu-
lar water flow [6].
The canalicular secretion of glutathione [3] and HCO3
- [4] are the main driving force for
the generation of the canalicular bile salt-independent bile flow. Canalicular HCO3
- secretion
has been reported to be regulated by glucagon [7]. This pancreatic hormone leads to increased
intracellular cAMP levels in hepatocytes, PKA activation, and stimulation of AE2 exchange
activity [7], as well as enhanced AQP8-mediated water permeability at the canalicular mem-
brane [8]. Interestingly, there is evidence supporting that, in hepatocytes under basal condi-
tions, the water channel AQP8, the Cl-/HCO3
- exchanger AE2 and the glutathione carrier
MRP2 are present in pericanalicular vesicles that migrate to the canalicular membrane upon
glucagon stimulation [8].
Obstructive cholestasis represents a wide range of liver pathologies where a mechanical
blockage in the bile ducts prevents bile from flowing into duodenum; as a consequence, it
leads to retention of biliary constituents in the liver and in the obstructed bile ducts. Among
these hepatopathies, gallstone disease secondary to cholelithiasis, biliary atresia, primary scle-
rosis cholangitis (PSC), and late-stage primary biliary cholangitis/cirrhosis (PBC) represent
prototypic pathologies with an obstructive cholestatic component [9].
Common bile duct ligation (BDL) is a useful animal model for the study of changes occur-
ring in obstructive cholestatic pathologies. Most of the changes in the expression of hepatic
transport proteins (both in hepatocytes and cholangiocytes) reported in this model are consid-
ered as adaptive changes tending to minimize cellular damage induced by retained, potentially
toxic, biliary constituents, such as bile salts and bilirubin [10]. These adaptive changes, several
of which have been confirmed in patients with obstructive cholestasis due to late-stage PBC
[11,12], involve the following: i) increased expression of enzymes engaged in the detoxification
of biliary constituents, ii) inhibition of endogenous bile salt synthesis, iii) downregulation of
the basolateral uptake systems such as the Na+-taurocholate cotransporter protein (NTCP)
and the organic anion transporting protein 1 (OATP1), iv) downregulation of canalicular
transporters BSEP, MRP2 and AQP8, and v) increased expression of basolateral export pumps
[13]. Interestingly, adaptive changes in hepatocellular transporters were reported to occur
early after BDL, in an attempt to prevent irreversible alterations from occurring at earlier
times. Indeed, downregulation of the basolateral uptake system NTCP [14], OATP1, OATP3,
and OATP4 [15], downregulation of the canalicular export pumps BSEP and MRP2 [16], and
upregulation of the basolateral export transporters OSTα/OSTβ [12], MRP3 and MRP4
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[15,17], were apparent as soon as 3 days after BDL. Thus far, however, the regulation of AE2
expression and activity in hepatocytes under cholestatic conditions remains to be investigated.
Therefore, we evaluated here the expression, localization and activity of AE2 in hepatocytes
after BDL in the rat.
Materials and methods
Animals and treatments
Male Wistar rats (Harlan) weighing approximately 250 g were housed under a controlled envi-
ronment (12 hr light/12 hr dark; temperature, 22–24˚C), and received a standard diet and
water ad libitum in the animal facility of the CIMA, University of Navarra. All animal handling
and surgical procedures were carried out in strict accordance with the Guide for the Care and
Use of Laboratory Animals of the National Institutes of Health and were approved by the
Committee of Ethics for Animal Experimentation (CEEA) of the University of Navarra. The
surgical procedures were performed under continuous inhalation anesthesia. Isoflurane 5%
with oxygen (1 L/min) was used for the induction of anesthesia (2–3 min) in an induction
chamber. The rats were then placed in maintenance anesthesia at 1–1.5% isoflurane with 0.6
L/min oxygen. Animals were maintained at a normal body temperature using thermal pads.
With rats under inhalation anesthesia, the common bile duct was double ligated close to the
hepatic hilum and cut between ligatures. Controls underwent a sham surgery, consisting in
exposure, but not ligation, of the common bile duct. BDL was maintained for 4 days, a time
period sufficient for adaptive response involving most hepatocellular transporter to occur (see
above, Introduction section). After 4 days, a blood sample was taken for biochemical determi-
nation of cholestatic and hepatocellular damage markers, and a liver sample was obtained by
partial hepatectomy for western blot analysis, histology and immunofluorescence for AE2.
Then, the liver was perfused with collagenase type IV (Sigma) for hepatocyte isolation, as pre-
viously described [18].
Biochemical plasma determinations
Plasma levels of total alkaline phosphatase (ALP), bilirubin and transaminases (AST and ALT)
were determined in a Hitachi 911 analyzer (Roche/Hitachi, Indianapolis, IN), including a nor-
malizing external control.
Liver histology
For conventional light microscopy, liver tissues were fixed in 4% neutral buffered formalde-
hyde solution and embedded in paraffin. Then, 4-μm-thick sections were stained with hema-
toxylin and eosin. The samples were coded and examined by a pathologist (G.B.P.), who was
unaware of the animals’ treatment.
Measurement of the Na+-independent Cl-/HCO3
- anion exchange (AE)
activity in primary cultured hepatocytes
The AE2 activity was measured in hepatocytes as the rate of spontaneous recovery of pHi, after
the induction of intracellular alkalinization, by administration and further withdrawal of the
cell-permeant weak acid, propionate. For this purpose, isolated hepatocytes were seeded on
sterile 12-mm glass coverslips and cultured in DMEM F-12 + Glutamax (Gibco) culture
medium with 10% FBS and penicillin/streptomycin, and cultured for 24 h. After that, the cells
attached to the glass coverslips were loaded with the pH-sensitive probe 2´-7´-bis-(2-carbox-
yethyl)-5(6)-carboxyfluorescein-acetoxymethylester (BCECF-AM), and placed on the
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thermostatic chamber of a fluorescence microscope, where a mercury lamp excites the BCEC-
F-AM-loaded cells. After an initial perfusion with Krebs-Ringer HCO3
- buffer (KRB), cells
were perfused for 4 min with a KRB-propionate buffer. Fluorescence emission was recorded,
and the obtained data were further analyzed using the Aquacosmos software. Rates of pHi
recovery was measured as δpHi/δt from the tangent to the experimental plot; transmembrane
acid fluxes (or equivalent transmembrane base fluxes, i.e. JOH-) were calculated as ßtot x δpHi/
δt, ßtot being the total intracellular buffering power in the presence of CO2/HCO3
-, estimated
as described [19].
The exchange activity measured as indicated above only assesses the function of AE2 local-
ized in the plasma membrane, which is just a fraction of the total amount of AE2 present in
the cell. For AE2 activity to reflect total AE2 content, exocytic targeting of internalized AE2 to
the plasma membrane must be promoted by elevating cAMP levels. For this purpose, both
KRB and KRB-propionate buffers were supplemented with a “stimulatory mixture” containing
the permeant cAMP analogue dibutyryl-cAMP (Sigma-Aldrich, 100 μM), the phosphodiester-
ase inhibitor, IBMX (Sigma-Aldrich, 100 μM), and the adenylate cyclase activator, forskolin
(Sigma-Aldrich, 3 μM). Whereas AE2 activity measured under stimulated conditions reflects
total AE2 content, the percentage increase in AE2 activity from basal to stimulated conditions
reflects the fraction of AE2 that was internalized under the first condition.
Analysis of AE2 mRNA expression by quantitative real-time PCR
Freshly isolated hepatocytes were lysed for extraction of total RNA by using the TRI Reagent
(Sigma). Extracted RNA was resuspended in diethylpyrocarbonate (DEPC, Sigma)-treated
water, and quantified by UV spectrometry using the NanoDrop ND-1000 spectrometer
(NanoDrop Technologies). Total RNA (1 μg, denatured at 70ºC during 3 min) was reversed
transcribed into complementary DNA (cDNA). Levels of the three AE2 mRNA variants were
determined by quantitative real-time PCR on resultant cDNA in an iCycler iQ5 Apparatus
(Bio-Rad Laboratories), using specific primers for each variant, i.e. AE2a, AE2b1 and AE2b2
isoforms. Glyceraldehyde phosphate dehydrogenase (GAPDH) was used as the housekeeping
gene for normalization of data. AE2 mRNA levels in BDL and SHAM rat hepatocytes were
estimated from the cycle threshold (Ct) values obtained for each sample, and normalized to
GAPDH mRNA levels according to the following equation: Relative AE2 mRNA level =
1.8(CtGAPDH-CtAe2) (an overall PCR efficiency of 80% was assumed).
Assessment of AE2 subcellular localization
AE2 protein content was evaluated by western blot of total hepatocyte membranes. For this
purpose, homogenates from liver samples obtained by 15 up-and-down strokes with a loose-
fitting Dounce homogenizer in 4 volumes of 0.3 M sucrose (MP Biomedicals, Solon, OH), con-
taining a mixture of protease inhibitors (Sigma Chemical Co., 1:1000) were subjected to low-
speed centrifugation (500g, 10 min) to obtain post-nuclear supernatants. This fraction was
then centrifuged at 200,000g for 60 min at 4ºC, yielding the total liver membrane fractions
[20].
In order to evaluate AE2 distribution between plasma membrane and microsomal mem-
brane, these two membrane fractions were obtained by differential centrifugation, as previ-
ously described [20]. Briefly, the post-nuclear fractions obtained from liver homogenates as
described above were subjected to centrifugation at 200,000g for 60 min at 4˚C on a discontin-
uous 1.3 M sucrose gradient. Then, the membrane band was removed, and further purified
on a 9% to 60% linear sucrose gradient, to yield the plasma membrane (PM) fraction. The
remaining gradient was sonicated and centrifuged at 17,000g for 30 minutes. The resulting
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supernatant was centrifuged again at 200,000g for 60 min, to yield the intracellular microsomal
membrane (IM) fraction.
Proteins in total membrane and PM and IM fractions were determined according to Lowry
et al. [21] by using bovine serum albumin as standard. Western blots of total membrane and
membrane fractions were performed by using a rabbit antibody against mouse AE2 (Alpha
Diagnostics), a mouse antibody against ß-actin (Sigma), and the corresponding horseradish
peroxidase-conjugated secondary antibodies (Thermo Scientific, Rockford, IL). Protein bands
were detected by an enhanced chemiluminescence detection system (Thermo Scientific).
Autoradiographs were obtained by exposing the membranes to Amersham Hyperfilm ECL
(GE Healthcare Limited, Chalfont St. Giles, UK). Densitometric analysis of the developed
bands was performed using ImageJ Software.
To evaluate the intracellular distribution of AE2, a liver lobe was excised 4 days after BDL
or SHAM surgery, frozen immediately in liquid nitrogen-precooled isopentane, and stored at
−70˚C for further immunofluorescent staining and confocal microscopy analysis, as described
previously [22]. Liver slices were fixed, permeabilized, and incubated with the antibody against
AE2 (1:100, overnight), and canaliculi were delimited by staining occludin (Invitrogen, 1:100,
overnight), followed by incubation with the respective Cy2 and Cy3-conjugated secondary
antibodies (Jackson ImmunoResearch, 1:200, 2h). Confocal images were obtained by using a
Confocal Nikon C1 Plus microscope.
Statistical analysis
Data belonging to BDL rats were compared to SHAM group using the unpaired Student’s t-
test, after confirming that the data met appropriate assumptions (normality, homogenous vari-
ance and independent sampling). When a non-parametric test was required, the Mann-Whit-
ney U-test was employed. A two-tailed p<0.05 value was considered statistically significant.
Results
Biochemical and histological parameters after 4 days of BDL
As shown in Table 1, plasma levels of the cholestasis markers ALP and total bilirubin were
found elevated after 4 days of BDL. Hepatic transaminase levels (AST and ALT), which are
indicative of hepatocyte integrity, were also found to be elevated, in agreement with the focal
necrosis observed in hematoxylin and eosin-stained slides (Fig 1C). Effective establishing of
the obstructive cholestatic model was also confirmed by the observation of the apparent dilata-
tion and proliferation of bile ducts (Fig 1B).
AE activity in primary cultured hepatocytes
Hepatocytes isolated from BDL and SHAM rats were cultured for 24 h to allow for a correct
cell attachment and reproducible AE activity measurements, as previously reported in hepato-
cytes [23] and hepatic cell lines [24]. Fig 2A shows representative traces of changes in pHi of
Table 1. Plasma levels of alkaline phosphatase (ALP), total bilirubin, AST and ALT after BDL.
ALP (U/L) Bilirubin (mg/dL) AST (U/L) ALT (U/L)
SHAM 119 ± 15 0.1 ± 0.0 256 ± 31 54 ± 7
BDL 602 ± 140� 7.9 ± 1.7� 1413 ± 106� 636 ± 67�
Results are mean ± SEM
�p<0.05 vs. SHAM, n = 3 each.
https://doi.org/10.1371/journal.pone.0212215.t001
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perfused SHAM and BDL rat hepatocytes showing the recovering acidification that follows the
alkalinization elicited by propionate removal (see Materials and methods), and results from
AE2-mediated HCO3
- secretion (demarcated zone in the curves). Inset graph shows the pHi
changes with time during the phase of recovering acidification, expressed as the percent of the
initial, maximum pHi in hepatocytes; the slope of the curves, indicative of the rate of pHi
recovery, directly depends on AE activity. This parameter was decreased in the BDL group
(Fig 2A, inset). However, under cAMP-stimulating conditions, the rate of pHi recovery was
increased to the same extent in both SHAM and BDL hepatocytes. Indeed, calculated JOH- val-
ues (Fig 2B) indicated that BDL leads to a significant decrease in baseline AE activity. Under
cAMP-stimulating conditions, however, activities of both SHAM and BDL hepatocytes were
increased above baseline values, reaching similar values in both BDL and SHAM hepatocytes.
These findings strongly suggest that the decrease in AE activity after BDL might be associated
to abnormal internalization of AE2; after stimulation with cAMP, AE2-containing intracellular
vesicles would be reinserted into the canalicular membrane, allowing for restoration of the AE
activity.
AE2 mRNA expression levels
The expression of all the hepatic isoforms of AE2 mRNA (i.e. AE2a, AE2b1 and AE2b2 vari-
ants), was quantified by quantitative Real-Time PCR in isolated hepatocyte samples. AE2
mRNA levels in the BDL group were not significantly different from those in SHAM group
(Fig 2A), indicating that there is no change in AE2 expression after BDL.
Intracellular distribution of AE2
Fig 3C shows that AE2 protein is encountered in both IM and PM fractions. BDL leads to a
decrease in the expression of AE2 protein in PM, with no modification of its expression in IM.
This decrease in the expression of AE2 in PM, together with the lack of decrease in the expres-
sion of AE2 in total membrane (Fig 3B), is consistent with deficient apical insertion of
AE2-containing vesicles (and/or with endocytic AE2 internalization) following BDL. The lack
of any detectable increase in AE2 expression in IM after BDL appears to be related to the fact
that, in hepatocytes under basal conditions, AE2 mainly resides in subapical vesicles; this
would induce changes in the expression of AE2 in IM fraction beyond the sensitivity of the
Western blot assay. A main subapical AE2 localization in BDL group was also apparent by con-
focal microscopy, where the transporter is barely visible in the canalicular membrane of some
canaliculi, but mainly present in numerous intracellular vesicular structures (Fig 4, arrows,
middle bottom panel). On the other hand, in the SHAM group (Fig 4), AE2 staining is clearly
visible in the canalicular membrane, as well as in some intracellular vesicles (Fig 4, arrows,
middle upper panel).
Discussion
Our results provide strong evidence for obstructive cholestasis leading to decreased anion
exchange activity in hepatocytes, due to low canalicular expresion of AE2, which is seemingly
redistributed to pericanalicular intracellular vesicles. While neither AE2 mRNA levels nor AE2
protein expression in total membranes were modified in hepatocytes after 4 days of BDL, the
Fig 1. Representative microscopy images of hematoxilin and eosin-stained liver slices from SHAM and BDL
animals. (A) Conserved histological architecture corresponding to the SHAM group. (B) Pronounced dilatation and
proliferation of bile ducts induced by BDL. (C) Necrotic areas (delineated by a dotted line) infiltrated by neutrofils
(arrowheads) in BDL livers. Scale line = 50 μm. cv = central vein; bd = bile duct.
https://doi.org/10.1371/journal.pone.0212215.g001
Hepatocellular adaptive downregulation of Cl-/HCO3- exchange activity under obstructive cholestasis
PLOS ONE | https://doi.org/10.1371/journal.pone.0212215 February 21, 2019 7 / 15
Hepatocellular adaptive downregulation of Cl-/HCO3- exchange activity under obstructive cholestasis
PLOS ONE | https://doi.org/10.1371/journal.pone.0212215 February 21, 2019 8 / 15
expression of AE2 was found to be decreased in the PM fraction. Our finding of recovery of
the AE activity in BDL hepatocytes to SHAM values upon cAMP stimulation is consistent with
cAMP-induced exocytic insertion of pericanalicular AE2-containing vesicles. Actually, AE2
mainly resides in subapical vesicles [25], that can be exocytosed to the canalicular membrane
on demand, as reported to occur under stimulation with glucagon, a cAMP-elevating agent
[26]. It was also reported that, as soon as after 2 days of BDL, glucagon-stimulated cAMP syn-
thesis is impaired by bile salt-dependent PKC-α activation [27,28], at least in part by a decrease
in glucagon receptors in the sinusoidal membrane [29]. It was also shown that pro-inflamma-
tory cytokines, which are elevated both in blood and in hepatic tissue after BDL [30], dimin-
ished cholangiocyte cAMP synthesis and AE2 membrane insertion, via generation of NO [31].
Interestingly, also in hepatocytes, BDL diminishes cAMP production [27] and increases the
levels of NO induced by cytokines [32]. Therefore, alteration of the normal targeting of this
transporter by impaired cAMP exocytic stimulation could contribute to the decrease in the
PM expression of AE2 and diminished AE activity observed in our experiments.
In addition to altered targeting to its membrane domain, AE2 might undergo exacerbated
endocytic internalization. AE2 is localized in cholesterol- and caveolin-enriched "raft" micro-
domains in the canalicular membrane [35]. It was recently described that, in estradiol 17ß-D-
glucuronide-induced cholestasis, the canalicular transporters BSEP and MRP2 undergo a shift
from raft to non-raft canalicular microdomains, from where they can be endocytosed in a cla-
thrin-dependent fashion [33]. Since PKC-α activation was reported to be crucial in estradiol
17ß-D-glucuronide-induced transporter endocytosis, this mechanism is also likely to occur in
BDL rats. In line with this, an increased activation of this kinase by translocation from the
cytosol to the membrane fraction was reported in hepatocytes isolated after only 2 days of BDL
[27], a phenomenon attributed to the intracellular accumulation of bile salts due to the
obstructive process [34].
Irrespective of the mechanisms involved, an adaptive downregulation of AE2 function in
obstructive cholestasis may be functionally associated with simultaneous downregulation of
AQP8 [20], an apical water channel that shares with AE2 the same intracellular vesicles [25,35]
and the same pro-exocytic stimulus via the glucagon/cAMP/PKA signaling pathway [8,36,37].
However, the fate of these transporters during cholestasis seems to be different; whereas AQP8
protein expression drops via post-transcriptional mechanisms by 3 days of the obstructive pro-
cess [20], transcriptional expression and total levels of AE2 protein remained unaltered even
after 4 days of cholestasis. This difference may be explained by different mechanisms or tim-
ings of intracellular degradation; while AE2 degradation mechanisms have not been character-
ized yet, AQP8 proteolysis is lysosomal in nature under cholestatic conditions [38].
Differences in the breakdown susceptibility has also been reported for MRP2 and BSEP in
obstructive cholestasis despite both transporters share the same pericanalicular vesicles, with
BSEP being more resilient to intracellular degradation [39]. Regardless the causes involved, a
differential degradation status may explain why AE2 is responsive to cAMP in hepatocytes
from animals with extrahepatic cholestasis (see Fig 1), but AQP8 is not [20]. Trafficking to
lysosomes is regarded as irreversible [40], so that transporters entering this pathway can no
Fig 2. Changes in hepatocyte anion exchange activity induced by BDL. (A) Representative traces of changes in intracellular pH
(pHi) of perfused rat hepatocytes showing the recovering acidification that follows the alkalinization elicited by propionate removal,
and results from AE2-mediated HCO3
- secretion (demarcated zone in the curves). Inset graph shows the pHi changes with time,
indicative of AE activity, during the phase of recovering acidification, expressed as the percent of the initial, maximum pHi in BDL
and SHAM hepatocytes, under the presence or absence of a stimulatory mixture (SM: dibutyryl cyclic AMP, IBMX and forskolin) in
the perfusion buffers. (B) Anion exchange (AE) activity, expressed as JOH-, in primary cultured hepatocytes from BDL and SHAM
rats, in the presence or absence of SM in the perfusion buffers. Results are mean ± SEM, n = 20 to 60 cells per preparation, from 3
independent cellular preparations per experimental group.
https://doi.org/10.1371/journal.pone.0212215.g002
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longer be recycled back to the apical membrane. A similar irreversible phenomenon occurs
with MRP2 in endotoxin-induced cholestasis; MRP2 can only be recruited for apical reinser-
tion shortly after the cholestatic insult, when MRP2 remains associated with early, but not
with late endosomal compartments [41].
Fig 3. Changes in hepatocellular AE2 expression induced by BDL. (A) Expression of AE2 mRNA variants in
hepatocytes isolated from BDL and SHAM rats (values are given as percentage of those in SHAM control). Results are
mean ± SEM, n = 4 each. (B) Expression of AE2 protein in total membrane obtained from liver homogenates.
Differences in sample loading were corrected by the densitometric signal of the respective β-actin band. An arbitrary
value of 100 was assigned to the SHAM band with the highest densitometric signal. Results are mean ± SEM, n = 4
each. (C) Expression of AE2 protein in plasma membrane (PM) and intracellular microsomal membrane (IM)
fractions. Differences in sample loading were corrected by the densitometric signal of the respective β-actin band.
Densitometric data were expressed as percentage of SHAM values. Results are mean ± SEM, n = 6 each. �p<0.05 vs.
SHAM.
https://doi.org/10.1371/journal.pone.0212215.g003
Fig 4. Changes in subcellular localization of AE2 induced by BDL. Representative confocal images of SHAM (upper panels) and BDL (lower panels) liver sections.
Fluorescent immunostaining was performed for AE2 (green) and occludin (red). In SHAM, AE2 is localized in the canalicular zone (arrowheads, demarcated by
occludin) and also in some intracellular vesicles (upper panels). BDL induced a clear internalization of AE2, thus leading to a significant diminution of AE2 in the
canalicular zone (arrowheads, lower panels) and the consequent increase in the number of AE2-positive intracellular vesicles.
https://doi.org/10.1371/journal.pone.0212215.g004
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Although it is difficult to establish with certainty how important is the downregulation in
AE2 activity for the adaptive reduction of bile production under biliary obstructive conditions,
an analysis of the potential contribution of HCO3
- output to bile flow generation may provide
some hints. It has been reported that, following bile flow obstruction, a decrease in bile flow of
80%-90% occurs [42]. Since HCO3
- was proposed to play a similar quantitative role in the gen-
eration of the canalicular bile salt-independent bile flow to glutathione [6], and the biliary
secretion of both osmotic agents accounts for at least 50% of bile flow in the rat [43], the down-
regulation of AE2 activity reported here should be indeed relevant to the adaptive response
aimed to decrease canalicular bile production in obstructive cholestasis. This is more so con-
sidering that most of the bile generation fall is expected to occur at expense of the bile salt-
independent fraction of bile flow, since bile salt output is better preserved in cholestasis [44].
The presumed reduction in canalicular bile flow generation caused by this change would act in
concert with other similar changes in canalicular transporters involved in bile formation (e.g.,
MRP2, BSEP). This should help to protect hepatocellular tight junctional integrity from the
increase in biliary pressure, and to prevent biliary infarcts leading to leakage of bile containing
millimolar concentrations of bile acids into the parenchyma via disrupted canals of Hering,
thus triggering bile salt-induced hepatocyte cell death [45]. These adaptive modulations in
response to obstructive cholestasis may explain why it is needed several weeks or months of
biliary obstruction for irreversible liver damage to occur [46].
In conclusion, our results indicate a downregulation of AE2 exchange activity due to AE2
internalization, as a novel adaptive mechanism in cholestasis. Our results may contribute to a
deep understanding of the mechanisms involved in this adaptive response, and this appears
relevant to envisage new therapeutics options aimed to enhance this beneficial response, and
preserve liver integrity in chronic cholestasis.
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